This article was downloaded by: [Fondren Library, Rice University ]
On: 21 November 2014, At: 05:20
Publisher: Taylor & Francis
Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered office: Mortimer
House, 37-41 Mortimer Street, London W1T 3JH, UK
Bioscience, Biotechnology, and Biochemistry
Publication details, including instructions for authors and subscription information:
Asymmetric Trans-esterification of meso-2,5-
Dibromoadipate and Synthesis of Optically Active
cis-2,5-Disubstituted Pyrrolidines
Naoshi Ozasaa, Kyohei Tokiokaa & Yukio Yamamotoa
a Graduate School of Human and Environmental Studies, Kyoto University, Yoshida, Kyoto
606-01, Japan
Published online: 12 Jun 2014.
To cite this article: Naoshi Ozasa, Kyohei Tokioka & Yukio Yamamoto (1995) Asymmetric Trans-esterification of meso-2,5-
Dibromoadipate and Synthesis of Optically Active cis-2,5-Disubstituted Pyrrolidines, Bioscience, Biotechnology, and
PLEASE SCROLL DOWN FOR ARTICLE
Taylor & Francis makes every effort to ensure the accuracy of all the information (the “Content”) contained
in the publications on our platform. However, Taylor & Francis, our agents, and our licensors make no
representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of
the Content. Any opinions and views expressed in this publication are the opinions and views of the authors,
and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied
upon and should be independently verified with primary sources of information. Taylor and Francis shall
not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other
liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to or
arising out of the use of the Content.
This article may be used for research, teaching, and private study purposes. Any substantial or systematic
reproduction, redistribution, reselling, loan, sub-licensing, systematic supply, or distribution in any
form to anyone is expressly forbidden. Terms & Conditions of access and use can be found at http://